Skip to Main Content

Paper Details

Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.
Pharmacoeconomics
4
2022
CAP, PSA, Prostate Cancer, Prostate-specific antigen, men, participants, prostate cancer, prostate-specific antigen
Author NameAffiliation
Fredrik WiklundKarolinska Institute
Freddie C HamdyUniversity of Oxford
David E NealUniversity of Oxford
  • 1 - 3

Datasets

Release 1.2